Vascular endothelial growth factor expression levels of gingiva in gingivitis and periodontitis patients with/without diabetes mellitus

Inflammation Research

Volumn 59, Issue 7, 2010, Pages 543-549

  Keles, Gonca Cayir ^a   Cetinkaya, Burcu Ozkan ^a   Eroglu, Cafer ^a   Simsek, S Burcak ^b   Kahraman, Hakki ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Goztepe Oral and Dental Health Center   (Turkey)

Author keywords

Diabetes mellitus; MRNA expression; Periodontal disease; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GINGIVA; GINGIVITIS; HUMAN; HUMAN TISSUE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; AGED; DIABETES MELLITUS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PERIODONTAL DISEASE;

ADULT; AGED; DIABETES MELLITUS; GINGIVA; GINGIVITIS; HUMANS; MIDDLE AGED; PERIODONTAL DISEASES; PERIODONTITIS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955710188     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0158-8     Document Type: Article

References (55)

1. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res. 1998;33:491-9.
2. Honda T, Domon H, Okui T, Kajita K, Amanuma R, Yamazaki K. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol. 2006; 144:35-40.
3. Rodríguez-Martínez M, Patiño-Marín N, Loyola-Rodríguez JP, Brito-Orta MD. Gingivitis and periodontitis as antagonistic modulators of gingival perfusion. J Periodontol. 2006;77: 1643-50.
4. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
5. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996;32A:2413-22.
6. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol. 1999;70:848-52.
7. Suthin K, Matsushita K, Machigashira M, et al. Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingival fibroblasts. J Periodontal Res. 2003; 38:90-6.
8. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-39.
9. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem. 1991;47:219-23.
10. Nakagawa K, Chen YX, Ishibashi H, Yonemitsu Y, Murata T, Hata Y, et al. Angiogenesis and its regulation: roles of vascular endothelial cell growth factor. Semin Thromb Hemost. 2000;26:61-6.
11. Sakuta T, Matsushita K, Yamaguchi N, Oyama T, Motani R, Koga T, et al. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. J Med Microbiol. 2001;50:233-7.
12. Unlu F, Guneri PG, Hekimgil M, Yesilbek B, Boyacioglu H. Expression of vascular endothelial growth factor in human periodontal tissues: comparison of healthy and diabetic patients. J Periodontol. 2003;74:181-7.
13. Cetinkaya BO, Keles GC, Ayas B, Sakallioglu EE, Acikgoz G. The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. J Periodontol. 2007;78:1129-35.
14. Prapulla DV, Sujatha PB, Pradeep AR. Gingival crevicular fluid VEGF levels in periodontal health and disease. J Periodontol. 2007;78:1783-7.
15. OyamaT, Sakuta T,MatsushitaK,Maruyama I,Nagaoka S, ToriiM. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture. J Periodontol. 2000;71:1546-53.
16. Chapple CC, Kumar RK, Hunter N. Vascular remodelling in chronic inflammatory periodontal disease. J Oral Pathol Med. 2000;29:500-6.
17. Cohen DW, Friedman LA, Shapiro J, Kyle GC, Franklin S. Diabetes mellitus and periodontal disease: two-year longitudinal observations, I. J Periodontol. 1970;41:709-12.
18. Rylander H, Ramberg P, Blohme G, Lindhe J. Prevalence of periodontal disease in young diabetics. J Clin Periodontol. 1987;14:38-43.
19. de Pommereau V, Dargent-Paré C, Robert JJ, Brion M. Periodontal status in insulin-dependent diabetic adolescents. J Clin Periodontol. 1992;19:628-32.
20. Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol. 2001;6:138-45.
21. Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol. 1996;1:1-36.
22. Loe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329-34.
23. Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med. 1995;332:1210-7.
24. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol. 1998;3:51-61.
25. Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr Res. 1998;44:873-5.
26. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes. 1999;48:1899-906.
27. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113-9.
28. HernandezC,BurgosR,CantonA,Garcia-Arumi J,SeguraRM, Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care. 2001;24:516-21.
29. deVrieseAS,TiltonRG,ElgerM,StephanCC,KrizW,LameireNH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol. 2001;12:993-1000.
30. Petrovic MG, Korosec P, Kosnik M, Osredkar J, Hawlina M, Peterlin B, et al. Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Mol Vis. 2008;14:1382-7.
31. Nakamura S, Iwasaki N, FunatsuH, Kitano S, Iwamoto Y. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247:21-6.
32. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev. 2003;23:117-45.
33. Di Marco GS, Alam A, Dol F, Corvol P, Gasc JM, Larger E. Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.Mol Med. 2008;14:705-14.
34. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001;49:554-60.
35. Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, et al. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007;116:I31-7.
36. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615-25.
37. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol. 2001;72:1254-7.
38. Guneri P, Unlu F, Yesilbek B, Bayraktar F, Kokuludag A, Hekimgil M, et al. Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodontol. 2004;75:91-7.
39. Sakallioglu EE, Aliyev E, Lutfioglu M, Yavuz U, Acikgoz G. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig. 2007;11:115-20.
40. Lundy FT, Shaw C, McKinnell J, Lamey PJ, Linden GJ. Calcitonin gene-related peptide in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol. 1999;26:212-6.
41. Seguier S, Godeau G, Brousse N. Collagen fibers and inflammatory cells in healthy and diseased human gingival tissues: a comparative and quantitative study by immunohistochemistry and automated image analysis. J Periodontol. 2000;71:1079-85.
42. Bogren A, Teles R, Torresyap G, Haffajee AD, Socransky SS, Lindhe J, et al. A three-year prospective study of adult subjects with gingivitis, I: clinical periodontal parameters. J Clin Periodontol. 2007;34:1-6. (Pubitemid 44963471)
43. Zheng P, Chen H, Shi S, Jepsen S, Eberhard J. Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. J Clin Periodontol. 2006;33:797-802.
44. Keles GC, Cetinkaya BO, Simsek SB, Koprulu D, Kahraman H. The role of periodontal disease on acute phase proteins in patients with coronary heart disease and diabetes. Turk JMed Sci. 2007;37:39-44.
45. Silness J, Loe H. Periodontal disease in pregnancy, II: correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121-35.
46. Loe H, Silness J. Periodontal disease in pregnancy, I: prevalence and severity. Acta Odontol Scand. 1963;21:533-51.
47. Hirose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K. Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol. 2001;72:590-7.
48. Stove J, Schoniger R, Huch K, Brenner R, Gunther KP, Puhl W, et al. Effects of dexamethasone on proteoglycan content and gene expression of IL-1beta-stimulated osteoarthrotic chondrocytes in vitro. Acta Orthop Scand. 2002;73:562-7.
49. Yamamoto T, Feng L, Mizuno T, Hirose S, Kawasaki K, Yaoita E, et al. Expression ofmRNAfor natriuretic peptide receptor subtypes in bovine kidney. Am J Physiol. 1994;267:F318-24.
50. Tokoro Y, Yamamoto T, Hara K. IL-1 beta mRNA as the predominant inflammatory cytokine transcript: correlation with inflammatory cell infiltration into human gingiva. J Oral Pathol Med. 1996;25:225-31.
51. Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N. Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci. 1996;104:562-9.
52. Oliver RC, Tervonen T. Diabetes: a risk factor for periodontitis in adults? J Periodontol. 1994;65:530-8.
53. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995;372:83-7.
54. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998;101:1219-24.
55. Tremolada G, Lattanzio R, Mazzolari G, Zerbini G. The therapeutic potential of VEGF inhibition in diabetic microvascular complications. Am J Cardiovasc Drugs. 2007;7:393-8.